DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Vanda Pharmaceuticals Inc. of Upcoming Deadline

  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Vanda
  Pharmaceuticals Inc. of Upcoming Deadline

Business Wire

WILMINGTON, Del. -- August 12, 2013

Rigrodsky & Long, P.A.:

  *Do you, or did you, own shares of Vanda Pharmaceuticals Inc. (NASDAQ GM:
    VNDA)?
  *Did you purchase your shares before December 18, 2012, or between December
    18, 2012 and June 18, 2013?
  *Did you lose money in your investment in Vanda Pharmaceuticals Inc.?
  *Do you want to discuss your rights?

Rigrodsky & Long, P.A., including former Special Assistant United States
Attorney, Timothy J. MacFall, reminds shareholders of Vanda Pharmaceuticals
Inc. (“Vanda” or the “Company”) (NASDAQ GM: VNDA) of an upcoming deadline
involving a securities fraud class action lawsuit commenced against the
Company.

A complaint was filed in the United States District Court for the District of
Columbia on behalf of all persons or entities that purchased the common stock
of Vanda between December 18, 2012 and June 18, 2013, inclusive (the “Class
Period”), alleging violations of the Securities Exchange Act of 1934 against
the Company and certain of its officers (the “Complaint”). If you wish to
serve as lead plaintiff, you must move the Court no later than August 26,
2013.

If you purchased shares of Vanda during the Class Period, or purchased shares
prior to the Class Period and still hold Vanda, and wish to discuss this
action or have any questions concerning this notice or your rights or
interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of
Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, NY at
(888) 969-4242, by e-mail to info@rigrodskylong.com, or at:
http://www.rigrodskylong.com/investigations/vanda-pharmaceuticals-inc-vnda.

A lead plaintiff is a representative party acting on behalf of other class
members in directing the litigation. In order to be appointed lead plaintiff,
the Court must determine that the class member’s claim is typical of the
claims of other class members, and that the class member will adequately
represent the class. Your ability to share in any recovery is not, however,
affected by the decision whether or not to serve as a lead plaintiff. Any
member of the proposed class may move the court to serve as lead plaintiff
through counsel of their choice, or may choose to do nothing and remain an
absent class member.

While Rigrodsky & Long, P.A. did not file the Complaint in this matter, the
firm, with offices in Wilmington, Delaware and Garden City, New York,
regularly litigates securities class, derivative and direct actions,
shareholder rights litigation and corporate governance litigation, including
claims for breach of fiduciary duty and proxy violations in the Delaware Court
of Chancery and in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:

Rigrodsky & Long, P.A.
Timothy J. MacFall, Esquire
Peter Allocco
888-969-4242
516-683-3516
Fax: 302-654-7530
info@rigrodskylong.com
http://www.rigrodskylong.com